# Haleon plc > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Haleon plc). ## Overview Haleon plc is a consumer health company focused on everyday self-care and over-the-counter wellness products. Its portfolio includes oral health, vitamins and supplements, pain relief, respiratory, digestive and therapeutic skin health brands sold through retail and healthcare channels across global markets. It is listed in London and New York and operates as a standalone consumer health group. ## Products & services • Oral health products, including Sensodyne, parodontax and Polident • Pain relief medicines, including Advil, Panadol and Voltaren • Vitamins, minerals and supplements, including Centrum • Respiratory health products, including Otrivin and Theraflu • Digestive health and therapeutic skin health products - **Oral Health** (28%) — Toothpaste, mouthwash and denture-care brands for daily oral care. - **Pain Relief** (22%) — Analgesics and related products used for headache, muscle and fever relief. - **Vitamins, Minerals and Supplements** (18%) — Nutritional supplements and multivitamins for everyday health support. - **Respiratory Health** (12%) — Products used for congestion, cold and flu symptom relief. - **Digestive Health** (10%) — Over-the-counter products for digestive comfort and gastrointestinal support. - **Therapeutic Skin Health and Other** (10%) — Skin-health treatments and smaller adjacent consumer health categories. - Oral health products, including Sensodyne, parodontax and Polident - Pain relief medicines, including Advil, Panadol and Voltaren - Vitamins, minerals and supplements, including Centrum - Respiratory health products, including Otrivin and Theraflu - Digestive health and therapeutic skin health products ## Customers Haleon sells primarily to consumers through pharmacies, drugstores, mass retail and e-commerce, with products chosen for self-care, symptom relief and routine wellness. A meaningful part of demand is also influenced by healthcare professionals and pharmacists, who recommend trusted branded products such as Sensodyne, Voltaren and Centrum. The business serves both prescription-adjacent and pure over-the-counter usage occasions, which makes brand credibility and shelf presence important. - **Retail consumers** (primary) — Buy OTC health and wellness products for daily use, symptom relief and prevention. - **Pharmacists and healthcare professionals** (primary) — Influence product choice by recommending oral care, pain relief and respiratory brands. - **Pharmacies and drugstores** (primary) — Purchase Haleon brands for shelf placement and repeat consumer demand. - **Mass retail and grocery** (secondary) — Stock mainstream health brands that benefit from broad household penetration. - **E-commerce channels** (secondary) — Sell branded health products online to convenience-focused consumers. - Retail consumers buying self-care and everyday wellness products - Pharmacists and healthcare professionals recommending trusted brands - Pharmacies and drugstores stocking OTC health categories - Mass retail and grocery chains selling household health staples - Online shoppers seeking branded health products and repeat purchases ## Geography Haleon sells in multiple regions through a globally distributed consumer health platform, with international brands that are recognized in both developed and emerging markets. Its operating footprint spans the UK-listed corporate base, the US capital markets listing and a broad international commercial network. Geography matters because local regulation, consumer preferences and pharmacy-channel access affect brand mix and demand. - Global consumer health footprint across multiple regions - Strong exposure to developed pharmacy and retail markets - Brands sold internationally with local market adaptation - UK corporate base and dual listing in London and New York - Geography affects regulation, pricing and channel access ## Strategy Haleon's strategy is centered on brand-led consumer health categories where trust, recommendation and repeat purchase matter. The company emphasizes innovation, research and investment in priority categories while balancing growth investment, acquisitions optionality and a strong credit profile. Its portfolio structure is designed to support scale in daily-use health brands across retail and healthcare channels. - **Build category leadership in consumer health brands** (medium-term) — Scale and brand trust drive repeat purchasing and pharmacy recommendation. - **Support innovation and research-led product development** (medium-term) — New formats and claims help sustain relevance in crowded OTC categories. - **Preserve financial flexibility** (short-term) — A moderate leverage profile supports growth investment and shareholder returns. - Invest behind six core consumer health categories - Protect and extend globally recognized brands - Use innovation to defend shelf space and consumer loyalty - Maintain capital flexibility for growth and M&A - Balance investment with an investment-grade balance sheet ## Risks Haleon's main risks are competitive pressure in branded OTC categories, where consumer switching and retailer bargaining power can affect market share and shelf presence. The business is also exposed to regulatory and product-safety scrutiny because its brands sit in health-related categories sold across many jurisdictions. Global supply chain disruption, foreign exchange volatility and dependence on brand trust are additional industry-typical risks. - **Competition in OTC health categories** [high] — Consumers and pharmacies can switch among branded and private-label alternatives. - **Regulatory and product-safety exposure** [high] — Consumer health products are subject to rules on claims, ingredients and labeling. - **Supply chain disruption** [medium] — Manufacturing and distribution issues can limit product availability and service levels. - **Foreign exchange volatility** [medium] — International sales and costs create translation and transaction exposure. - Brand competition can pressure shelf space and consumer loyalty - Regulatory scrutiny is high because products are health-related - Supply chain and sourcing disruptions can affect availability - Foreign exchange moves can impact reported results and margins - Reliance on trusted brands makes reputation a key risk ## Accounting Haleon's reporting is influenced by estimates around intangible assets, provisions and other judgmental items typical of branded consumer businesses. The interim filing also highlights liquidity and going-concern assessment, while the company notes that several adjusted performance measures require exclusions of items not readily forecastable under IFRS. Because the business operates globally, foreign currency translation and constant-currency adjustments are also important for interpreting underlying performance. - **Adjusted performance measures** — Affects comparability with IFRS results and peer valuation multiples. - **Intangible assets and goodwill** — Can create large non-cash charges if brand values weaken. - **Foreign currency translation** — Can obscure underlying volume and pricing trends. - **Provisions and estimates** — Changes can shift period earnings materially. - Adjusted measures exclude items not easily forecast under IFRS - Intangible asset and goodwill judgments matter in a brand-heavy business - Provisions and contingencies can affect reported earnings - Foreign currency translation affects global reported results - Going-concern and liquidity disclosures support balance-sheet analysis --- *Last updated: 2026-09-28T12:03:56.247805+00:00*